These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28316439)

  • 21. Red cell alloimmunization in a transfused patient population: a study from a tertiary care hospital in north India.
    Thakral B; Saluja K; Sharma RR; Marwaha N
    Hematology; 2008 Oct; 13(5):313-8. PubMed ID: 18854096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of type and screen method compared to conventional antiglobulin crossmatch procedures for compatibility testing in Indian setting.
    Chaudhary R; Agarwal N
    Asian J Transfus Sci; 2011 Jul; 5(2):157-9. PubMed ID: 21897596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful transfusion of antigen positive blood to alloimmunised patients using a monocyte monolayer assay.
    Noumsi GT; Billingsley KL; Moulds JM
    Transfus Med; 2015 Apr; 25(2):92-100. PubMed ID: 25828731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An approach to incompatible cross-matched red cells: Our experience in a major regional blood transfusion center at Kolkata, Eastern India.
    Bhattacharya P; Samanta E; Afroza N; Naik A; Biswas R
    Asian J Transfus Sci; 2018; 12(1):51-56. PubMed ID: 29563676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A newly recognized blood group in domestic shorthair cats: the Mik red cell antigen.
    Weinstein NM; Blais MC; Harris K; Oakley DA; Aronson LR; Giger U
    J Vet Intern Med; 2007; 21(2):287-92. PubMed ID: 17427390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved graft survival for flow cytometry and antihuman globulin crossmatch-negative retransplant recipients.
    Kerman RH; Van Buren CT; Lewis RM; DeVera V; Baghdahsarian V; Gerolami K; Kahan BD
    Transplantation; 1990 Jan; 49(1):52-6. PubMed ID: 2301027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endovascular Treatment of Aortic Aneurysms and Blood Transfusion. What do We Need?
    Machado R; Loureiro L; Antunes I; Coutinho J; Almeida R
    Acta Med Port; 2016 May; 29(5):310-4. PubMed ID: 27649014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation.
    Gloor JM; DeGoey S; Ploeger N; Gebel H; Bray R; Moore SB; Dean PG; Stegall MD
    Transplantation; 2004 Jul; 78(2):221-7. PubMed ID: 15280682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [An evaluation of platelet transfusion response using HLA crossmatch-compatible donors in patients with platelet refractoriness].
    Hyun J; Lim YM; Park KD; Han BY; Kim YH; Han KS; Park MH
    Korean J Lab Med; 2009 Oct; 29(5):481-9. PubMed ID: 19893359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal management with crossmatch-compatible platelets for refractory patients: alloimmunization, response to transfusion, and clinical outcomes (CME).
    Wiita AP; Nambiar A
    Transfusion; 2012 Oct; 52(10):2146-54. PubMed ID: 23113654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experience with a cost-effective crossmatch protocol.
    Shulman IA; Nelson JM; Kent DR; Jacobs VL; Nakayama RK; Malone SA
    JAMA; 1985 Jul; 254(1):93-5. PubMed ID: 3999355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed hemolytic episodes due to anti-M.
    Furlong MB; Monaghan WP
    Transfusion; 1981; 21(1):45-9. PubMed ID: 7466906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies to low-incidence antigens and elimination of the antihuman globulin phase of the crossmatch-case report: anti-Wra.
    Wise SC; Larson PJ; Cook LO
    Immunohematology; 1997; 13(1):20-2. PubMed ID: 15387795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of previous erythrocyte alloimmunization and the type and screen at a large cancer center. A 4-year retrospective review.
    Havemann H; Lichtiger B
    Cancer; 1992 Jan; 69(1):252-5. PubMed ID: 1727671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flow cytometric crossmatch for kidney transplantation.
    Koktathong K; Vejbaesya S; Bejrachandra S; Pattanapanyasat K
    J Med Assoc Thai; 2005 Jun; 88(6):769-74. PubMed ID: 16083217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Survey of Blood Request Versus Blood Utilization at a University Hospital in Iran.
    Yazdi AP; Alipour M; Jahanbakhsh SS; Gharavifard M; Gilani MT
    Arch Bone Jt Surg; 2016 Jan; 4(1):75-9. PubMed ID: 26894224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of virtual crossmatch in sensitized patients awaiting heart transplantation.
    Stehlik J; Islam N; Hurst D; Kfoury AG; Movsesian MA; Fuller A; Delgado JC; Hammond ME; Gilbert EM; Renlund DG; Bader F; Fisher PW; Bull DA; Singhal AK; Eckels DD
    J Heart Lung Transplant; 2009 Nov; 28(11):1129-34. PubMed ID: 19782589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute and delayed hemolytic transfusion reactions secondary to HLA alloimmunization.
    Benson K; Agosti SJ; Latoni-Benedetti GE; Leparc GF
    Transfusion; 2003 Jun; 43(6):753-7. PubMed ID: 12757526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of incompatible crossmatch results in dogs admitted to a veterinary teaching hospital with no history of prior red blood cell transfusion.
    Odunayo A; Garraway K; Rohrbach BW; Rainey A; Stokes J
    J Am Vet Med Assoc; 2017 Feb; 250(3):303-308. PubMed ID: 28117642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of IgM-positive crossmatches on survival in heart transplant recipients.
    Scheinin SA; Radovancević B; Kimball P; Duncan JM; Van Buren CT; Frazier OH; Kerman R
    Tex Heart Inst J; 1995; 22(1):67-71. PubMed ID: 7787472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.